The effect of oral N-acetylcysteine on quantitative serum high sensitivity CRP and hemoglobin in hemodialysis patients
Phase 4
- Conditions
- End stage renal disease.End stage kidney diseaseN 18.5
- Registration Number
- IRCT2016111030821N1
- Lead Sponsor
- Vice Chancellor for research of Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients with positive CRP who were dialyzed at least three times per week for three months
Exclusion criteria: Patients with chronic inflammatory diseases such as rheumatoid arthritis and lupus, patients who take HRT drugs during menopause ,patients with malignant blood diseases such as myelodysplastic syndrome, lymphoma, leukemia, bone marrow aplasia and patients with HIV
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CRP. Timepoint: Before the intervention and one month after intervention. Method of measurement: ELIZA.
- Secondary Outcome Measures
Name Time Method Hemoglobin. Timepoint: Before the intervention and one month after intervention. Method of measurement: CBC.